4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-21-123185
SVP, Chief Business Officer sold 27,500 shares at $4.89 ($134,475)
- SVP, Chief Business Officer acquired 27,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Korbel Gregory Alan SVP, Chief Business Officer | 2021-10-01 | Option exercise | +27,500 | $0.92 | $25,300 | 44,667 | D: show line 1 in the form |
| Korbel Gregory Alan SVP, Chief Business Officer | 2021-10-01 | Sale | −27,500 | $4.89 | $134,475 | 17,167 | D: show line 2 in the form |
| Open-market sales · 27,500 sh · avg $4.89 · $134,475 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Korbel Gregory Alan SVP, Chief Business Officer | 2021-10-01 | Option exercise · Stock Option (right to Buy) | −27,500 | 25,245 | D: show line 3 in the form |
Loading xslF345X03/tm2129205-1_4seq1.xml…